{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:56:43Z","timestamp":1791572203087,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":2225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1593\/neo.07820","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:05:50Z","timestamp":1429794350000},"page":"340-IN3","source":"Crossref","is-referenced-by-count":37,"title":["The Growth Factor Midkine Antagonizes VEGF Signaling In Vitro and In Vivo"],"prefix":"10.1016","volume":"10","author":[{"given":"Edward Htun","family":"van der Horst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon T.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Chinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Coxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Polesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Ruefli-Brasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Wesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.07820_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1593\/neo.07820_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"10.1593\/neo.07820_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Shibuya","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1593\/neo.07820_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1044-579X(02)00133-5","article-title":"Angiogenesis and apoptosis","volume":"13","author":"Folkman","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1593\/neo.07820_bib5","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.07820_bib6","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1242\/jcs.01423","article-title":"\u03b14\u03b21- and \u03b16\u03b21-integrins are functional receptors for midkine, a heparin-binding growth factor","volume":"117","author":"Muramatsu","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1593\/neo.07820_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00450-6","article-title":"Midkine and pleiotrophin in neural development and cancer","volume":"204","author":"Kadomatsu","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1593\/neo.07820_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbrc.2005.05.160","article-title":"Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin\/midkine developmental gene family","volume":"333","author":"Herradon","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1593\/neo.07820_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1054\/bjoc.2000.1339","article-title":"Serum midkine levels are increased in patients with various types of carcinomas","volume":"83","author":"Ikematsu","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1593\/neo.07820_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1349-7006.2003.tb01494.x","article-title":"Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma","volume":"94","author":"Shimada","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1593\/neo.07820_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbrc.2007.04.183","article-title":"Midkine as a novel target for antibody therapy in osteosarcoma","volume":"358","author":"Maehara","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1593\/neo.07820_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijom.2006.09.004","article-title":"Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis","volume":"36","author":"Ruan","year":"2007","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1593\/neo.07820_bib13","first-page":"5152","article-title":"Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy","volume":"9","author":"Muramaki","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.07820_bib14","first-page":"1814","article-title":"An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis","volume":"57","author":"Choudhuri","year":"1997","journal-title":"Cancer Res"},{"key":"10.1593\/neo.07820_bib15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ijc.20643","article-title":"Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: novel heregulin\/HER3-stimulated signaling pathway in glioma","volume":"113","author":"van der Horst","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.07820_bib16","first-page":"123","article-title":"Angiogenesis assays in the chick CAM","volume":"294","author":"Storgard","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1593\/neo.07820_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ccr.2005.02.007","article-title":"Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin","volume":"7","author":"Satchi-Fainaro","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.07820_bib18","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/art.10546","article-title":"Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis","volume":"46","author":"Coxon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1593\/neo.07820_bib19","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1128\/MCB.22.8.2830-2841.2002","article-title":"Activated Notch4 inhibits angiogenesis: role of \u03b21-integrin activation","volume":"22","author":"Leong","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1593\/neo.07820_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/oxfordjournals.jbchem.a003231","article-title":"Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis","volume":"132","author":"Muramatsu","year":"2002","journal-title":"J Biochem (Tokyo)"},{"key":"10.1593\/neo.07820_bib21","first-page":"1), 2","article-title":"Vascular endothelial growth factor as a target for anticancer therapy","volume":"9(Supp","author":"Ferrara","year":"2004","journal-title":"Oncologist"},{"key":"10.1593\/neo.07820_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(03)00551-8","article-title":"TIMP-2 mediated inhibition of angiogenesis: an MMPindependent mechanism","volume":"114","author":"Seo","year":"2003","journal-title":"Cell"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558608800474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558608800474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:28:53Z","timestamp":1537687733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558608800474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1476558608800474"],"URL":"https:\/\/doi.org\/10.1593\/neo.07820","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}